These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26023257)

  • 1. Establishment of a syngeneic orthotopic model of prostate cancer in immunocompetent rats.
    Suzuki S; Naiki-Ito A; Kuno T; Punfa W; Long N; Kato H; Inaguma S; Komiya M; Shirai T; Takahashi S
    J Toxicol Pathol; 2015 Jan; 28(1):21-6. PubMed ID: 26023257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2'-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats.
    Nakanishi H; Takeuchi S; Kato K; Shimizu S; Kobayashi K; Tatematsu M; Shirai T
    Jpn J Cancer Res; 1996 Dec; 87(12):1218-26. PubMed ID: 9045956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
    Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
    Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers.
    Takahashi S; Inaguma S; Sakakibara M; Cho YM; Suzuki S; Ikeda Y; Cui L; Shirai T
    Prostate; 2002 Jun; 52(1):82-8. PubMed ID: 11992622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.
    Hillman GG; Wang Y; Che M; Raffoul JJ; Yudelev M; Kucuk O; Sarkar FH
    BMC Cancer; 2007 Jan; 7():4. PubMed ID: 17212824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer.
    Cunningham D; Zhang Q; Liu S; Parajuli KR; Nie Q; Ma L; Zhang A; Chen Z; You Z
    Am J Clin Exp Urol; 2018; 6(3):114-122. PubMed ID: 30038943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
    Eastham JA; Grafton W; Martin CM; Williams BJ
    J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models.
    Nolan K; Verzosa G; Cleaver T; Tippimanchai D; DePledge LN; Wang XJ; Young C; Le A; Doebele R; Li H; Malkoski SP
    Cancer Cell Int; 2020; 20():417. PubMed ID: 32874131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
    Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
    Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice.
    An Z; Wang X; Geller J; Moossa AR; Hoffman RM
    Prostate; 1998 Feb; 34(3):169-74. PubMed ID: 9492844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration.
    Frost GI; Lustgarten J; Dudouet B; Nyberg L; Hartley-Asp B; Borgström P
    Microvasc Res; 2005 Jan; 69(1-2):1-9. PubMed ID: 15797254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.
    Strömvall K; Lundholm M; Thysell E; Bergh A; Halin Bergström S
    PLoS One; 2017; 12(10):e0187086. PubMed ID: 29073272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer.
    Rembrink K; Romijn JC; van der Kwast TH; Rübben H; Schröder FH
    Prostate; 1997 May; 31(3):168-74. PubMed ID: 9167768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of bone metastasis.
    Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
    Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.
    van Duijn PW; Marques RB; Ziel-van der Made ACJ; van Zoggel HJAA; Aghai A; Berrevoets C; Debets R; Jenster G; Trapman J; van Weerden WM
    Prostate; 2018 Sep; 78(13):1013-1023. PubMed ID: 30133757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of linomide on local tumor growth and metastasis of the human hormone-resistant prostate cancer cell line PC3 in an orthotopic model.
    Bex A; Luboldt H; Sudermann T; Rembrink K; Otto T; Rübben H
    Eur Urol; 2000 May; 37(5):628-33. PubMed ID: 10765105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).
    Chang XH; Fu YW; Na WL; Wang J; Sun H; Cai L
    Anticancer Res; 1999; 19(5B):4199-202. PubMed ID: 10628375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic model for human prostate cancer using orthotopic implantation in nude mice.
    Stephenson RA; Dinney CP; Gohji K; Ordóñez NG; Killion JJ; Fidler IJ
    J Natl Cancer Inst; 1992 Jun; 84(12):951-7. PubMed ID: 1378502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host.
    Simons BW; Kothari V; Benzon B; Ghabili K; Hughes R; Zarif JC; Ross AE; Hurley PJ; Schaeffer EM
    Oncotarget; 2019 Dec; 10(64):6845-6854. PubMed ID: 31839878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.